Lumipulse® G SARS-CoV-2 Ag

For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection. 

The assay utilises proven CLEIA (chemiluminescent enzyme immunoassay) technology with results that are available in up to 35 minutes.

CE marked
Lumipulse® G SARS-CoV-2 Ag Immunoreaction Cartridges

Product number 260340

3 x 14 Tests
Lumipulse® G SARS-CoV-2 Ag Calibrators

Product number 231869

4 x 4 Concentrations
Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

  • Contact sales for information
  • Details
  • Conditions of sale
  • Documentation
  • Insights
  • FAQ
  • Related products
  • Product inquiry